Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FHTX
#2701
Foghorn Therapeutics Inc. Common Stock
5.680
0
+0.89%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+0.89%
Monthly Change
-3.97%
6 month change
+39.22%
Cambio anual
+39.22%
Cierres anteriores
5.630
0
Open
5.680
0
Bid
Ask
Low
5.680
0
High
5.680
0
Volumen
33
Markets
Acciones
Atención Sanitaria
FHTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
36.82 M
41.42 M
41.8 M
42.57 M
55.61 M
—
Valuation ratios
Enterprise value
653.48 M
846.18 M
219.51 M
194.21 M
207.04 M
729.79 M
Price to earnings ratio
—
-8.38
-2.48
-2.76
-2.99
-14.63
Price to sales ratio
—
644.51
14.06
7.93
11.46
44.83
Price to cash flow ratio
—
16.92
1.4
2.29
2.58
11.27
Price to book ratio
—
8.78
2 413.79
3.51
5.69
9.58
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.27
0.19
0.27
0.34
0.3
0.3
Return on equity %
0.47
1.05
972.32
1.27
1.9
1.14
Return on invested capital %
182.8
188.74
159.43
156.66
202.12
—
Gross margin %
100
100
100
100
100
400
Operating margin %
15.94 K
7 637.15
609.2
315.93
454.31
1 731.57
EBITDA margin %
—
—
—
—
—
—
Net margin %
16 K
7 680.06
566.36
288.1
383.15
1 429.78
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.12
9.44
6.37
4.11
3.73
11.67
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0.04
0.1
0.08
0.1
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.08
0
—
—
—
—
Long term debt to total equity ratio
0.13
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
1.35
4.66
2.81
1.83
1.46
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
2.72
1.26
1.91
1.01
4.55
Net current asset value per share
—
12.36
8.45
5.72
4.55
14.29
Tangible book value per share
—
2.61
0
1.84
0.83
4.45
Working capital per share
—
11.05
7.12
4.33
3.33
9.35
Book value per share
—
2.61
0
1.84
0.83
4.45
Noticias
Foghorn Therapeutics nombra a Ryan Maynard como director financiero
Foghorn Therapeutics nombra a Ryan Maynard director financiero
Foghorn Therapeutics names Ryan Maynard as chief financial officer
Jefferies initiates Foghorn Therapeutics stock with buy rating
Las mejores acciones de salud para este año según BTIG
Las mejores acciones del sector Salud para este año según BTIG
Top Healthcare Stocks for This Year According to BTIG
Foghorn Therapeutics reafirmada como Compra por BTIG, nombrada favorita para 1S26
Acción de Foghorn Therapeutics reafirmada como Compra por BTIG, nombrada mejor opción para 1S26
Foghorn Therapeutics stock reaffirmed as Buy by BTIG, named top pick for 1H26
Stifel reitera calificación de compra para Foghorn Therapeutics con objetivo de $12
Stifel reitera calificación de Compra para Foghorn Therapeutics con objetivo de 12 dólares